- Home
- BCDA vs EFOI Comparison
BCDA vs EFOI Comparison
Compare BCDA & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- EFOI
- Stock Information
- Founded
- BCDA N/A
- EFOI 1985
- Country
- BCDA United States
- EFOI United States
- Employees
- BCDA N/A
- EFOI N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- EFOI Building Products
- Sector
- BCDA Health Care
- EFOI Consumer Discretionary
- Exchange
- BCDA Nasdaq
- EFOI Nasdaq
- Market Cap
- BCDA 7.9M
- EFOI 7.0M
- IPO Year
- BCDA N/A
- EFOI 1994
- Fundamental
- Price
- BCDA $2.18
- EFOI $1.31
- Analyst Decision
- BCDA Strong Buy
- EFOI
- Analyst Count
- BCDA 1
- EFOI 0
- Target Price
- BCDA $25.00
- EFOI N/A
- AVG Volume (30 Days)
- BCDA 52.4K
- EFOI 7.6K
- Earning Date
- BCDA 11-13-2024
- EFOI 11-12-2024
- Dividend Yield
- BCDA N/A
- EFOI N/A
- EPS Growth
- BCDA N/A
- EFOI N/A
- EPS
- BCDA N/A
- EFOI N/A
- Revenue
- BCDA $71,000.00
- EFOI $5,975,000.00
- Revenue This Year
- BCDA N/A
- EFOI N/A
- Revenue Next Year
- BCDA N/A
- EFOI N/A
- P/E Ratio
- BCDA N/A
- EFOI N/A
- Revenue Growth
- BCDA N/A
- EFOI 49.86
- 52 Week Low
- BCDA $1.63
- EFOI $1.14
- 52 Week High
- BCDA $8.85
- EFOI $2.90
- Technical
- Relative Strength Index (RSI)
- BCDA 49.10
- EFOI 50.40
- Support Level
- BCDA $2.05
- EFOI $1.27
- Resistance Level
- BCDA $2.36
- EFOI $1.37
- Average True Range (ATR)
- BCDA 0.21
- EFOI 0.05
- MACD
- BCDA -0.00
- EFOI 0.01
- Stochastic Oscillator
- BCDA 46.43
- EFOI 66.67
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. It serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, wall-packs, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. It generates a majority of its sales from Military maritime products in the United States.